HIGHLIGHTS
- who: January et al. from the Shanghai Changzheng Hospital, China Medicine, Central South University, China have published the research: Interferon gamma-related gene signature based on anti-tumor immunity predicts glioma patient prognosis, in the Journal: (JOURNAL)
- how: The potential relationship between the risk scoring model and clinicopathological features was analyzed using a nomogram. The authors analyzed the risk scoring model in predicting glioma prognosis based on immune status of TME its relationship with immune checkpoint molecule expression and its potential role in predicting immunotherapy outcomes. The authors applied the Wilcox test to compare the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.